Mitsubishi Ufj Trust & Banking Corp Biogen Inc. Transaction History

Mitsubishi Ufj Trust & Banking Corp

$41.8 Billion
Q2 2025

A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Biogen Inc. stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 81,195 shares of BIIB stock, worth $11.9 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

81,195

Previous 77,233 5.13%

Holding current value

$11.9 Million

Previous $10.6 Million 3.51%

% of portfolio

0.02%

Previous 0.03%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	BUY	$113.38 - $135.49 $449,211 - $536,811	3,962 Added 5.13%	81,195 $10.2 Million
Q1 2025 May 09, 2025	SELL	$133.43 - $153.27 $584,556 - $671,475	-4,381 Reduced 5.37%	77,233 $10.6 Million
Q4 2024 Feb 11, 2025	BUY	$146.47 - $191.55 $357,826 - $467,956	2,443 Added 3.09%	81,614 $12.5 Million
Q3 2024 Nov 12, 2024	BUY	$189.07 - $236.8 $102,854 - $128,819	544 Added 0.69%	79,171 $15.3 Million
Q2 2024 Aug 08, 2024	BUY	$190.52 - $236.72 $109,358 - $135,877	574 Added 0.74%	78,627 $18.2 Million
Q1 2024 May 10, 2024	SELL	$212.02 - $267.71 $1.33 Million - $1.67 Million	-6,254 Reduced 7.42%	78,053 $16.8 Million
Q4 2023 Feb 09, 2024	SELL	$222.59 - $267.94 $2.77 Million - $3.34 Million	-12,466 Reduced 12.88%	84,307 $21.8 Million
Q3 2023 Nov 09, 2023	SELL	$253.3 - $285.89 $308,772 - $348,499	-1,219 Reduced 1.24%	96,773 $24.9 Million
Q2 2023 Aug 08, 2023	SELL	$275.25 - $318.06 $8.31 Million - $9.61 Million	-30,202 Reduced 23.56%	97,992 $27.9 Million
Q1 2023 May 10, 2023	SELL	$256.56 - $292.34 $7.28 Million - $8.3 Million	-28,381 Reduced 18.13%	128,194 $35.6 Million
Q4 2022 Feb 10, 2023	SELL	$252.44 - $306.72 $3.46 Million - $4.21 Million	-13,721 Reduced 8.06%	156,575 $43.4 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $1.11 Million - $1.53 Million	5,713 Added 3.47%	170,296 $45.5 Million
Q2 2022 Aug 09, 2022	BUY	$187.54 - $223.02 $2.14 Million - $2.55 Million	11,432 Added 7.46%	164,583 $33.6 Million
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $1.67 Million - $2.11 Million	-8,630 Reduced 5.33%	153,151 $32.3 Million
Q4 2021 Feb 09, 2022	SELL	$223.92 - $287.77 $5.39 Million - $6.93 Million	-24,082 Reduced 12.96%	161,781 $38.8 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $4.21 Million - $5.49 Million	-14,872 Reduced 7.41%	185,863 $52.6 Million
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $6.82 Million - $10.9 Million	-26,316 Reduced 11.59%	200,735 $69.5 Million
Q1 2021 May 12, 2021	SELL	$242.95 - $284.63 $1.03 Million - $1.21 Million	-4,253 Reduced 1.84%	227,051 $59.6 Million
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $30,241 - $45,520	128 Added 0.06%	231,304 $56.6 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $1.66 Million - $1.92 Million	6,266 Added 2.79%	231,176 $65.6 Million
Q2 2020 Sep 11, 2020	BUY	$258.66 - $342.55 $9.56 Million - $12.7 Million	36,955 Added 19.66%	224,910 $60.2 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $7.58 Million - $10 Million	-29,294 Reduced 13.48%	187,955 $60.2 Million
Q1 2020 May 13, 2020	BUY	$268.85 - $341.04 $2.59 Million - $3.28 Million	9,623 Added 4.63%	217,249 $68.7 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $554,771 - $766,560	2,521 Added 1.23%	207,626 $61.6 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $4.93 Million - $5.53 Million	22,661 Added 12.42%	205,105 $47.3 Million
Q2 2019 Aug 07, 2019	BUY	$219.29 - $241.72 $1.19 Million - $1.31 Million	5,420 Added 3.06%	182,444 $43.7 Million
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $318,346 - $497,932	-1,469 Reduced 0.82%	177,024 $41.2 Million
Q4 2018 Feb 12, 2019	BUY	$278.5 - $352.75 $104,994 - $132,986	377 Added 0.21%	178,493 $53.7 Million
Q3 2018 Nov 13, 2018	SELL	$293.51 - $383.83 $78.6 Million - $103 Million	-267,822 Reduced 60.06%	178,116 $62.9 Million
Q2 2018 Aug 10, 2018	BUY	$257.52 - $306.91 $2.08 Million - $2.48 Million	8,073 Added 1.84%	445,938 $129 Million
Q1 2018 May 11, 2018	BUY	$260.13 - $367.91 $1.04 Million - $1.47 Million	4,009 Added 0.92%	437,865 $120 Million
Q4 2017 Feb 09, 2018	SELL	$307.64 - $344.58 $3.57 Million - $4 Million	-11,609 Reduced 2.61%	433,856 $138 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $125 Million - $147 Million	445,465	445,465 $139 Million

Others Institutions Holding BIIB

# of Institutions

1,024

Shares Held

131M

Call Options Held

2.87M

Put Options Held

2.57M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.

Account

Mitsubishi Ufj Trust & Banking Corp Biogen Inc. Transaction History